Trulieve Cannabis Corp. (TCNNF)
TCNNF Stock Price Chart
Explore Trulieve Cannabis Corp. interactive price chart. Choose custom timeframes to analyze TCNNF price movements and trends.
TCNNF Company Profile
Discover essential business fundamentals and corporate details for Trulieve Cannabis Corp. (TCNNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Sept 2018
Employees
6.00K
Website
https://www.trulieve.comCEO
Kimberly Rivers
Description
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
TCNNF Financial Timeline
Browse a chronological timeline of Trulieve Cannabis Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.06, while revenue estimate is $287.91M.
Earnings released on 6 Aug 2025
EPS came in at -$0.07 falling short of the estimated -$0.07 by -7.57%, while revenue for the quarter reached $302.09M , beating expectations by +5.21%.
Earnings released on 7 May 2025
EPS came in at -$0.17 falling short of the estimated -$0.08 by -112.50%, while revenue for the quarter reached $297.76M , missing expectations by -2.08%.
Earnings released on 26 Feb 2025
EPS came in at -$0.27 falling short of the estimated -$0.18 by -50.00%, while revenue for the quarter reached $301.10M , beating expectations by +2.96%.
Earnings released on 5 Nov 2024
EPS came in at -$0.33 falling short of the estimated -$0.13 by -153.85%, while revenue for the quarter reached $284.28M , missing expectations by -2.82%.
Earnings released on 6 Aug 2024
EPS came in at -$0.06 surpassing the estimated -$0.08 by +25.00%, while revenue for the quarter reached $303.44M , beating expectations by +3.29%.
Earnings released on 9 May 2024
EPS came in at -$0.12 falling short of the estimated -$0.10 by -20.00%, while revenue for the quarter reached $297.62M , beating expectations by +4.03%.
Earnings released on 29 Feb 2024
EPS came in at -$0.18 falling short of the estimated -$0.16 by -12.50%, while revenue for the quarter reached $286.97M , beating expectations by +7.10%.
Earnings released on 9 Nov 2023
EPS came in at -$0.14 surpassing the estimated -$0.17 by +17.65%, while revenue for the quarter reached $275.21M , beating expectations by +2.38%.
Earnings released on 9 Aug 2023
EPS came in at -$0.51 falling short of the estimated -$0.19 by -168.42%, while revenue for the quarter reached $281.80M , beating expectations by +0.26%.
Earnings released on 10 May 2023
EPS came in at -$0.34 falling short of the estimated -$0.16 by -112.50%, while revenue for the quarter reached $289.10M , missing expectations by -1.30%.
Earnings released on 8 Mar 2023
EPS came in at -$0.41 falling short of the estimated -$0.11 by -272.73%, while revenue for the quarter reached $302.20M , missing expectations by -0.86%.
Earnings released on 9 Nov 2022
EPS came in at $0.02 surpassing the estimated -$0.05 by +140.00%, while revenue for the quarter reached $300.79M , missing expectations by -2.14%.
Earnings released on 10 Aug 2022
EPS came in at -$0.12 falling short of the estimated -$0.02 by -531.58%, while revenue for the quarter reached $320.28M , missing expectations by -0.42%.
Earnings released on 12 May 2022
EPS came in at -$0.17 falling short of the estimated -$0.02 by -691.43%, while revenue for the quarter reached $318.35M , beating expectations by +3.90%.
Earnings released on 30 Mar 2022
EPS came in at -$0.46 falling short of the estimated $0.18 by -355.56%, while revenue for the quarter reached $305.35M , beating expectations by +0.34%.
Earnings released on 15 Nov 2021
EPS came in at $0.17 falling short of the estimated $0.24 by -29.17%, while revenue for the quarter reached $224.09M , missing expectations by -3.66%.
Earnings released on 12 Aug 2021
EPS came in at $0.31 surpassing the estimated $0.28 by +10.71%, while revenue for the quarter reached $215.12M .
Earnings released on 13 May 2021
EPS came in at $0.25 falling short of the estimated $0.26 by -3.85%, while revenue for the quarter reached $193.82M , beating expectations by +3.03%.
Earnings released on 23 Mar 2021
EPS came in at $0.31 surpassing the estimated $0.25 by +24.00%, while revenue for the quarter reached $168.44M .
Earnings released on 17 Nov 2020
EPS came in at $0.04 falling short of the estimated $0.23 by -82.61%, while revenue for the quarter reached $136.27M , missing expectations by -39.15%.
TCNNF Stock Performance
Access detailed TCNNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.